Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study
Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival. Hypericum japonicum Thunb. (Tianjihuang), a traditional Chinese medicine exhibits promising anticancer properties. This study aim...
Saved in:
| Main Authors: | Bixing Liang, Wenyu Wu, Fan He, Bing Yang, Dongxin Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02633-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation
by: Ni Zhang, et al.
Published: (2025-04-01) -
Network pharmacology integrated with molecular docking and experimental validation elucidates the therapeutic potential of Forsythiae Fructus extract against hepatitis B virus-related hepatocellular carcinoma
by: Fuqing Chen, et al.
Published: (2025-06-01) -
Exploration of the mechanism of Polyphyllin I against hepatocellular carcinoma based on network pharmacology, molecular docking and experimental validation
by: Yilong Chen, et al.
Published: (2025-05-01) -
Integrative network pharmacology and experimental validation reveal emodin derivatives as potential therapeutics for hepatocellular carcinoma
by: Wirawan Adikusuma, et al.
Published: (2025-07-01) -
Decoding the therapeutic mechanism of Conocarpus lancifolius in hepatocellular carcinoma: network pharmacology, molecular docking, and LC-MS QTOF insights
by: Poojaben M. Prajapati, et al.
Published: (2025-06-01)